Preparation of bromfenac sodium/chitosan nanoparticles loaded fibrin-binding amniotic membrane and its effect on rabbit corneal neovascularization in vitro
|更新时间:2025-01-15
|
Preparation of bromfenac sodium/chitosan nanoparticles loaded fibrin-binding amniotic membrane and its effect on rabbit corneal neovascularization in vitro
Journal of Army Medical UniversityVol. 35, Issue 6, Pages: 495-499(2013)
作者机构:
重庆医科大学附属第一医院眼科,重庆市眼科学重点实验室
作者简介:
基金信息:
DOI:
CLC:R772.2;R944.9;R318.08
Published:2013,
Published Online:30 March 2013,
稿件说明:
移动端阅览
WU GUIYU, ZHAO MIN, JI YAN. Preparation of bromfenac sodium/chitosan nanoparticles loaded fibrin-binding amniotic membrane and its effect on rabbit corneal neovascularization in vitro. [J]. Journal of army medical university, 2013, 35(6): 495-499.
DOI:
WU GUIYU, ZHAO MIN, JI YAN. Preparation of bromfenac sodium/chitosan nanoparticles loaded fibrin-binding amniotic membrane and its effect on rabbit corneal neovascularization in vitro. [J]. Journal of army medical university, 2013, 35(6): 495-499.DOI:
Preparation of bromfenac sodium/chitosan nanoparticles loaded fibrin-binding amniotic membrane and its effect on rabbit corneal neovascularization in vitro
and its effect on rabbit corneal neovascularization (CNV). Methods The ionotro
pic gelation was used to produce bromfenac sodium/chitosan nanoparticles (BF/CS). After its physic properties were identified
the BF/CS nanoparticles were mixed with fibrin glue (FG)
and then sprayed to the surface of amniotic membrane (AM). After BF/CS-FBAM was obtained
the morphological changes and drug release
in vitro
were observed and measured. The effect of BF/CS-FBAM for CNV was observed in rabbit corneal alkali burn model
meanwhile the expression of vascular endothelial growth factor (VEGF) in the cornea were quantified by reverse transcription-quantitative PCR (RT-qPCR). Results The nanoparticles were smooth and spherical
in a diameter of 548.7±14.4 nm
and had a positive zeta potential of 29.8±2.2 mV. The encapsulation efficiency and loading capacity of BF/CS nanoparticles were (67.11±4.56)% and (57.71±5.38)% respectively. The nanoparticle-loaded fibrin gel was firmly adhered to the AM. Moreover
nanoparticles were coated within FBAM symmetrically
and its surface had a netted structure. The BF released from the BF/CS-FBAM was sustained for approximately 14 d
in vitro
. In rabbit corneal alkali burn model
BF/CS-FBAM group and BF/CS group had better curative effect in attenuating inflammatory reaction
anti-CNV and down-regulating VEGF than control group in every time point after injury (
P
<
0.05). Meanwhile
the expression of VEGF in BF/CS-FBAM group was significantly lower than BF/CS group in the 14th and 21st day after injury (
P
<
0.05). Conclusion As a novel biological implantable material
the fabricated BF/CS-FBAM locally releases BF in a sustained way and inhibits the generation of CNV.
Establishment of poly(DL-lactide-co-glycolide) nanoparticle drug delivery system and its maintenance for bioactivity of basic fibroblast growth factor
Clinical efficacy of bromfenac sodium hydrate ophthalmic solution after sub-bowman keratomileusis for correction of high myopia and myopic astigmatism
Preparation of zinc oxide/polyvinyl alcohol nanofibers and its therapeutic effects on wound in rats
Related Author
LIU Minghua1
CHEN Xiangyu1
ZHANG Yi1
XIAO Yao1
LI Tao3
LI Rong2
FU Weilin1
ZENG Feng1
Related Institution
State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University)
Department of Emergency, 3Center for Joint Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Ophthalmology, Fuling Central Hospital of Chongqing
Department of Ophthalmology, University-Town Hospital of Chongqing Medical University
Department of Ophthalmology, Guizhou Provincial People’s Hospital